title: Mepolizumab does not alter levels of eosinophils, T cells, and mast cells in the duodenal mucosa in eosinophilic esophagitis.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Conus
authors.forename: Alex
authors.initials: A
authors.lastname: Straumann
authors.forename: Eva
authors.initials: E
authors.lastname: Bettler
authors.forename: Hans-Uwe
authors.initials: HU
authors.lastname: Simon
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004386:Duodenum / Q000473:pathology*; D004802:Eosinophilia / Q000188:drug therapy* / Q000276:immunology; D004804:Eosinophils / Q000187:drug effects*; D004941:Esophagitis / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors*; D007413:Intestinal Mucosa / Q000473:pathology*; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D013601:T-Lymphocytes / Q000187:drug effects*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; C434107:mepolizumab